
What Brands Get Wrong About Local Marketing
Multi-location brands should have a built-in advantage in local markets. Their scale brings name recognition, buying power and operational precision. Centralized oversight helps ensure brand consistency and enables enterprise-wide efficiency.
But when that centralization overrides local nuance, it becomes a liability. What was meant to drive uniformity often results in customer experiences that feel impersonal, disconnected and out of step with community expectations.
Consumers expect more from national brands: more accuracy, more convenience, more relevance. When a brand with national resources fails to deliver a seamless and personalized experience, the disappointment is magnified.
Striking the right balance between centralized brand control and local judgment is no longer optional. It's fundamental. Here's where enterprise brands often fall short and what they can do to earn relevance and trust at the local level.
False Tradeoff: Brand Control Vs. Local Relevance
The paradox of local marketing is this: the more tightly a brand controls its local presence, the less local it feels. But swinging too far in the opposite direction and giving every location full autonomy leads to fragmented messaging, inconsistent execution and eroded brand trust.
The solution lies in clarity and knowing what should be controlled centrally and what should be shaped locally.
Take business listings, store hours, review responses, and social media posts. These are often managed by headquarters in the name of brand consistency. But in chasing uniformity, national teams can strip out the very context customers care about.
When I was 16, I worked closing shifts at a Dairy Queen in a small town in North Dakota. Officially, we closed at 8 p.m. But on game nights when the local high school teams played, we stayed open late and let everyone know with a hand-written sign on the door.
That wasn't a corporate directive. It was a decision made by the local manager who understood that the next closest restaurant was a 30-minute drive and that staying open late was good for business and good for the brand.
Consistency across locations is important. But when it overrides the flexibility to stay open late for game night, it signals detachment, not discipline.
How To Scale Without Becoming Generic
A persistent myth in enterprise marketing is that you must choose: enforce brand standards or empower local teams. That binary thinking is outdated.
Too much centralization results in sterile messaging that doesn't resonate. A national campaign claiming 'We make the best soda' will sound tone-deaf in Minnesota, where people say 'pop,' and in Georgia, where everything is a 'Coke.' The message wasn't built for them so it doesn't land.
But full decentralization introduces risk. When every franchise or regional manager runs their own playbook, it creates compliance issues, off-brand communications and chaos masquerading as creativity.
The real unlock lies in a hybrid approach: centralized strategy with distributed execution.
Corporate defines the brand voice, sets clear guardrails and delivers tools, templates and structured data. Local teams then bring that strategy to life by adapting the tone, spotlighting community events and responding to real-world context in real time.
With the right platform and workflows, this isn't just possible. It's scalable.
The Real Competition Isn't Who You Think It Is
Another misstep is benchmarking exclusively against other national brands. That's not how customers make local decisions.
When someone's choosing where to grab lunch, they're not pitting your national chain against another big-name competitor. They're deciding between you and the family-run deli across the street—the one that posts daily on Instagram, remembers their order and has five stars on Google.
While enterprise marketers obsess over brand lift and campaign reach, customers care about something simpler: who's open, who's nearby and who feels human.
In that moment of decision, the competition isn't always bigger or better. It's just closer, more present and more trusted.
That's why local context isn't sentimental. It's strategic. Ignore it, and you don't just lose share. You lose relevance.
The New Discovery Landscape
It used to be that local discovery meant ranking high on Google Maps. If you cracked the top three, you were in business. Not anymore.
Today's consumers move fluidly across platforms like TikTok, Yelp, ChatGPT, Instagram, voice assistants and more, often without ever visiting your website. Younger audiences, especially, are more likely to find businesses through social media than through traditional search engines. And AI-generated answers don't come with dashboards or paid ad placements.
Worse still, these systems rely on a wide constellation of data sources, many of which brands have stopped thinking about like MapQuest or Yellow Pages. Inaccurate or outdated information in any one of these can result in misinformation, misrepresentation, or outright invisibility.
This shift from search engine optimization to discovery optimization is seismic. You're no longer trying to rank for keywords. You're trying to be the best answer to a locally relevant question everywhere someone might ask it.
Local Isn't A Channel. It's The Brand.
The brands that succeed at the local level aren't simply adapting national campaigns. They're operationalizing local relevance—embedding it into their data, decisions and daily execution.
They strike the right balance between central governance and local agility. They treat structured content as infrastructure, not an afterthought. And they recognize that every listing, review, photo and neighborhood initiative is a brand touchpoint—one that must be accurate, timely and contextually aware.
Because whether it's keeping the lights on after a Friday night game in rural North Dakota or adding a vegan menu item in Chelsea, customers notice. And in an era where trust is earned in moments, how you show up locally isn't just a detail. It's the brand.
Forbes Communications Council is an invitation-only community for executives in successful public relations, media strategy, creative and advertising agencies. Do I qualify?
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a few seconds ago
- Yahoo
Warren Buffett's Advice: 'If You Aren't Willing To Own A Stock For Ten Years, Don't Even Think About Owning It For Ten Minutes'
Billionaire investor Warren Buffett is known for his emphasis on long-term investments. He focuses on businesses that he believes will maintain a competitive edge for decades to come. What Happened: Buffett's 'buy and hold' strategy is the key to his advice for Apple investors to not get caught up in short-term metrics. 'Nobody buys a farm based on whether they think it's going to rain next year. They buy it because they think it's a good investment over 10 or 20 years,' he said in an interview in 2018. Buffett's investment decisions are rooted in the longevity of a business, not its current performance. This approach led him to invest in See's Candies in 1972 and Coca-Cola in 1988, both of which turned out to be profitable investments that he still owns today. Also Read: Forget 'Wealth': Warren Buffett Says This Word Is the True Measure of Success In his 1996 letter to shareholders Buffett wrote, "Put together a portfolio of companies whose aggregate earnings march upward over the years, and so also will the portfolio's market value. If you aren't willing to own a stock for ten years, don't even think about owning it for ten minutes." Buffett's core principle of long-term investment can be applied to almost every purchase we make. Whether it's deciding to buy a home, clothing, appliances, or furniture, the value of an investment usually increases the longer you hold onto it. Buffett's strategy serves as a reminder to consider the long-term value of an investment, whether it's a stock or a new car. If the Oracle of Omaha serves as any example, the discipline to buy things only when you really, really like them pays off. Read Next Warren Buffett's Advice for Overpriced Stocks: 'Zip up Your Wallet, Take a Vacation, and Come Back in a Few Years To Buy Stocks at Cheap Prices' Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Warren Buffett's Advice: 'If You Aren't Willing To Own A Stock For Ten Years, Don't Even Think About Owning It For Ten Minutes' originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten
Yahoo
a few seconds ago
- Yahoo
Ex-Treasury Secretary Calls Trump Worse Than Nixon After Jobs Report Tantrum
President Donald Trump's inability to face the facts is yet another sign he's tilting towards tyranny, according to one former White House Cabinet member. After the release of a weak July jobs report and dismal updates to May and June numbers on Friday, a furious Trump sacked the top official at the Bureau of Labor Statistics in a post on Truth Social. 'The Economy is BOOMING under 'TRUMP,'' he declared while accusing BLS Commissioner Dr. Erika McEntarfer and her agency of manipulating employment statistics 'for political purposes.' Following McEntarfer's unceremonious ouster, Larry Summers, the treasury secretary under former President Bill Clinton, warned that Trump's actions are a dire sign for democracy when he appeared on the Sunday episode of ABC's 'This Week.' 'This is way beyond anything that Richard Nixon ever did,' Summers told host George Stephanopoulos. It's 'preposterous' for Trump to accuse the Bureau of Labor Statistics of warping employment numbers for political gain, Summers said, explaining that jobs data is meticulously calculated by hundreds of experts following rigorous formulas. Alarmed that the president would act like the figures were anything but objective, Summers told Stephanopoulos, 'This is the stuff of democracies giving way to authoritarianism.' Offering several more examples of Trump's autocratic impulses, he added, 'Firing statisticians goes with threatening the heads of newspapers, it goes with launching assaults on universities, it goes with launching assaults on law firms that defend clients that the elected boss finds uncongenial. This is really scary stuff.' Trump's labor report tantrum follows his decision to sue Wall Street Journal reporters and the paper's owner, Rupert Murdoch, over reports detailing his alleged connections to convicted sex offender Jeffrey Epstein. He also appeared to strong-arm television giant Paramount into a $16 million settlement just as it was seeking federal approval for a major merger with Skydance Media. The president successfully threatened to strip billions in funding from universities to drop their diversity, equity and inclusion policies while also accusing the institutions of failing to address antisemitism on campus. Before that, Trump pressured nine of the nation's top legal outfits into providing a collective $1 billion in pro bono services to avoid retaliation for their connections to federal prosecutors who oversaw investigations related to his first impeachment and the criminal investigations into Trump supporters' Jan. 6, 2021, attack on the U.S. Capitol. To Summers, the legal free-for-all and the tumult of Trump's ongoing tariff announcements seem like a recipe for economic instability. 'Who knows what business is going to be attacked next? Who knows what the rules are going to be?' he said. 'In an environment like that, what should a business do? It should sit, and it should wait.' Related... Trump Fires Labor Statistics Head In Meltdown Over Grim Jobs Report Senate Heads Home With No Deal On Nominations As Irate Trump Tells Schumer 'Go To Hell' It's Trump's Economy Now — And The Latest Financial Numbers Offer Some Warning Signs
Yahoo
a few seconds ago
- Yahoo
2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run
Key Points Hims & Hers Health is unlocking new sources of growth potential, and its balance sheet is flourishing. Doximity is a prime platform for advertisers, and the profits are pouring in. 10 stocks we like better than Hims & Hers Health › It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very personal process. You need to consider the type of stocks you want to buy, the industries and sectors you gravitate toward, the amount of capital you have to invest, and your own personal risk tolerance. If you have cash to invest in the stock market right now, and you're looking for growth stocks that could make smart additions to the basket of businesses you own, there are names to be found across a range of industries, including healthcare. Here are two healthcare stocks that have at least doubled over the past 12 months but still look poised to deliver favorable returns for shareholders in the next three to five years. 1. Hims & Hers Health Hims & Hers Health (NYSE: HIMS) has witnessed a stock run-up of more than 200% over the trailing-12-month period. In contrast, the S&P 500 is up only about 18% in that same time frame. This boom in the company's share price has occurred for a few reasons. Investors were particularly excited about the company's ability to offer affordable, compounded GLP-1 drugs for weight loss amid shortages of branded versions, and that fueled significant revenue growth and share-price appreciation. However, Hims & Hers can no longer mass-produce compounded drugs like semaglutide because the U.S. Food and Drug Administration declared the shortage resolved. While the company may still offer personalized doses where clinically applicable, its primary weight loss offerings are shifting to oral medications and liraglutide. In fact, Novo Nordisk, the maker of Wegovy (semaglutide for weight) and Ozempic (semaglutide for diabetes), ended its partnership with Hims & Hers, citing concerns over the latter company's promotion and sales of compounded semaglutide. While the company's offerings may evolve in the coming months and years, it has other sources of growth to lean on besides the weight loss segment. Hims & Hers' areas of focus include sexual health, hair loss, dermatology, mental health, and primary care. The platform also provides access to both over-the-counter and prescription treatments via online consultations with licensed healthcare professionals, and most of its revenue still comes from recurring subscriptions paid by healthcare consumers. The recent acquisition of Zava, a European digital health platform, seems to have boosted investor confidence in the future of the business outside of its ambitions in the weight loss industry. The addition of Zava to Hims & Hers' ecosystem will expand its reach into the U.K., Ireland, France, and Germany. Hims & Hers also plans to launch its platform in Canada in 2026. Revenue grew by 110% year over year in the first quarter, and the company is building upon an improving track record of profitability. Hims & Hers also delivered free cash flow of about $50 million in Q1. This business has a lot of potential. 2. Doximity Doximity (NYSE: DOCS) has seen shares pop by a bit more than 100% since this time one year ago. Doximity is known as the largest digital platform for U.S. medical professionals. It serves as a professional and social network for healthcare professionals including doctors, nurse practitioners, and physician assistants, and offers a wide variety of tools for communication, news, and career management. Doximity provides a curated newsfeed with the latest medical news and research relevant to different specialties, and also offers tools for job searches, salary comparisons, and reputation management. The platform even provides telehealth solutions, enabling virtual patient visits and consultations. The platform is free for healthcare professionals to use. This free access includes Doximity Dialer, a feature that allows secure communication with patients using a customized calling tool. The platform also offers free digital fax lines and access to Doximity Scribe, an AI-powered note-taking tool for verified clinicians. So, how does Doximity make money? From advertising and selling information. Doximity's platform is a prime digital marketing and advertising tool for pharmaceutical manufacturers and healthcare systems (like hospitals). These entities pay Doximity to advertise and promote their products and services to targeted medical professionals. Health systems and medical recruiting firms also pay Doximity to access its database of medical professionals for recruitment and hiring purposes. In Doximity's fiscal 2025, which ended March 31, revenue increased 20% from the prior fiscal year to $570.4 million. The company reported net income of $223.2 million, up 51% year over year, with free cash flow spiking 50% to $266.7 million. This healthcare stock is really an advertising business at its core, and a profitable one at that. These factors could induce some investors to take another long look at this top stock and I think it has room to run. Do the experts think Hims & Hers Health is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Hims & Hers Health make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,019% vs. just 178% for the S&P — that is beating the market by 841.12%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025 Rachel Warren has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Doximity and Hims & Hers Health. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. 2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run was originally published by The Motley Fool 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤